ResearcherNational Cancer Center HospitalActive in the last 2 years
Hidetoshi Kitamura
Matched on ORCID iD 0000-0002-6278-1450; OpenAlex author ID A5031487762. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 5
- Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1 treatment: A propensity sco… Co-author DOI 10.1016/j.pan.2025.08.017↗
- Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY. Co-author DOI 10.1111/jgh.16524↗
- Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2023.10.017↗
- Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for genomic profiling of unresectable pancr… Co-author DOI 10.1111/den.14423↗
- Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System … Co-author DOI 10.1007/s00535-022-01926-z↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chigusa Morizane · 4 shared papers, 2022–2025 · strength 0.59
- Paper Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after … DOI 10.1016/j.pan.2025.08.017↗
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Susumu Hijioka · 4 shared papers, 2022–2024 · strength 0.57
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE … DOI 10.1111/jgh.16524↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Takuji Okusaka · 4 shared papers, 2022–2024 · strength 0.57
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE … DOI 10.1111/jgh.16524↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Akihiro Ohba · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Hideki Ueno · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Go Ikeda · 3 shared papers, 2022–2023 · strength 0.41
- Paper Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. DOI 10.1016/j.pan.2023.10.017↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Shota Harai · 3 shared papers, 2022–2024 · strength 0.41
- Paper Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE … DOI 10.1111/jgh.16524↗
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Daiki Yamashige · 2 shared papers, 2023–2024 · strength 0.29
- Yuya Hisada · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Kotaro Takeshita · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Yasushi Yatabe · 2 shared papers, 2022–2023 · strength 0.24
- Paper Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for… DOI 10.1111/den.14423↗
- Paper Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meet… DOI 10.1007/s00535-022-01926-z↗
- Nobuaki Azemoto · 1 shared paper, 2025 · strength 0.19
- Hiroaki Yanagimoto · 1 shared paper, 2025 · strength 0.19
- Kunihiro Tsuji · 1 shared paper, 2025 · strength 0.19
- Keiko Kamei · 1 shared paper, 2025 · strength 0.19
- Kumiko Umemoto · 1 shared paper, 2025 · strength 0.19
- Takeshi Terashima · 1 shared paper, 2025 · strength 0.19
- Satoshi Kobayashi · 1 shared paper, 2025 · strength 0.19
- Kei Nakagawa · 1 shared paper, 2025 · strength 0.19
- Masafumi Ikeda · 1 shared paper, 2025 · strength 0.19
- Naohiro Okano · 1 shared paper, 2025 · strength 0.19
- Masato Ozaka · 1 shared paper, 2025 · strength 0.19
- Akiko Todaka · 1 shared paper, 2025 · strength 0.19
- Takafumi Mie · 1 shared paper, 2025 · strength 0.19
- Yasuyuki Kawamoto · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.